-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Fosbretabulin disodium is an anti-cancer medication that is commonly used to treat various types of cancer, such as breast cancer, ovarian cancer, and lung cancer.
The chemical compound is a type of bisabolane, which is a class of organic compounds that have a unique structure and properties.
In the chemical industry, fosbretabulin disodium is used as an intermediate in the production of other chemicals and pharmaceuticals.
Upstream Products
The production of fosbretabulin disodium involves several upstream products, which are raw materials and intermediate chemicals that are used in the manufacturing process.
One of the key upstream products is the chemical compound known as 2-nitropropane, which is used as a starting material to synthesize fosbretabulin disodium.
2-nitropropane is produced through a series of chemical reactions involving the reaction of acetone and nitric acid, followed by hydrogenation to remove the nitro group and substitution with a chloride group.
Another important upstream product for the production of fosbretabulin disodium is cis-1,2-diaminocyclohexane, which is a precursor to the bisabolane class of compounds.
This chemical is synthesized through a multi-step process that involves the reaction of cyclohexane with ammonia and hydrogenation to convert the primary amine to a secondary amine.
Downstream Products
Once fosbretabulin disodium is synthesized, it can be used as an intermediate in the production of other chemicals and pharmaceuticals.
One of the most common downstream products is the chemotherapy drug, paclitaxel, which is used to treat a variety of cancers.
Paclitaxel is synthesized by reacting fosbretabulin disodium with a variety of reagents, including dichloromethane, followed by a series of chemical reactions to introduce the taxane ring structure.
Another important downstream product is the anticancer drug, irinotecan, which is also used to treat a variety of cancers.
Irinotecan is synthesized by reacting fosbretabulin disodium with a reagent called SN-38, followed by a series of chemical reactions to introduce the topoisomerase inhibitor moiety.
In addition to these downstream pharmaceuticals, fosbretabulin disodium can also be used as an intermediate in the production of other chemicals, such as surfactants and dyes.
Manufacturing Process
The manufacturing process for fosbretabulin disodium involves several steps, including the synthesis of upstream products, the reaction of these materials to form the bisabolane scaffold, and the introduction of the disodium salt group.
The process can be broken down into the following steps:
- Synthesis of 2-nitropropane: This step involves the reaction of acetone and nitric acid, followed by hydrogenation to remove the nitro group and substitution with a chloride group.
- Synthesis of cis-1,2-diaminocyclohexane: This step involves the reaction of cyclohexane with ammonia and hydrogenation to convert the primary amine to a secondary amine.
- Synthesis of fosbretabulin disodium: This step involves the reaction of cis-1,2-diaminocyclohexane with a reagent called phthalic anhydride, followed by a series of chemical reactions to introduce the bisabolane scaffold.
The final step involves the introduction of the disodium salt group.
Challenges and Opportunities
The production of fosbretabulin disodium presents several challenges, including the need for specialized equipment and facilities, the requirement for strict quality control, and the potential for environmental impact.
However, there are also opportunities for innovation and growth in the production